APON(SZ:300753) Xin Lang Cai Jing·2025-09-24 07:12Group 1 - The core viewpoint of the news is the performance and market position of Aipeng Medical, which saw a stock price increase of 5.53% to 29.75 CNY per share, with a total market capitalization of 3.75 billion CNY [1] - Aipeng Medical specializes in the development, production, and sales of medical devices in the pain management and nasal care sectors, with revenue composition being 59.73% from pain management products, 29.40% from nasal and upper airway products, and 10.87% from other sources [1] - The company is located in the Jiangsu province and was established on October 30, 2001, with its listing date on December 13, 2018 [1] Group 2 - The North Trust Ruifeng Fund holds a significant position in Aipeng Medical, with its health lifestyle theme flexible allocation fund (001056) owning 120,000 shares, accounting for 4.43% of the fund's net value, ranking as the tenth largest holding [2] - The fund has achieved a year-to-date return of 27.84% and a one-year return of 60.98%, with a total fund size of 89.38 million CNY [2] - The fund manager, Pang Wenjie, has been in position for over 5 years, with the best fund return during his tenure being 44.46% [3]